XML 20 R5.htm IDEA: XBRL DOCUMENT v3.21.4
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)
Common Stock
LifeSci Acquisition II Corp
Common Stock
Additional Paid-in Capital
LifeSci Acquisition II Corp
Additional Paid-in Capital
Accumulated Deficit
LifeSci Acquisition II Corp
Accumulated Deficit
LifeSci Acquisition II Corp
Total
Balance at the beginning at Dec. 31, 2018   $ 827   $ 941,902   $ (57,492,746)   $ (56,550,017)
Balance at the beginning (in shares) at Dec. 31, 2018   8,273,865            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss           (18,468,776)   (18,468,776)
Balance at the end at Dec. 31, 2019   $ 839   1,374,319   (75,961,522)   (74,586,364)
Balance at the end (in shares) at Dec. 31, 2019   8,396,425            
Balance at the beginning at Dec. 17, 2019 $ 0   $ 0   $ 0   $ 0  
Balance at the beginning (in shares) at Dec. 17, 2019 0              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss         (1,000)   (1,000) (1,000)
Balance at the end at Jun. 30, 2020 $ 216 $ 856 24,784 1,611,049 (1,000) (106,135,338) 24,000 (106,135,338)
Balance at the end (in shares) at Jun. 30, 2020 2,156,250 2,765,097            
Balance at the beginning at Dec. 31, 2019   $ 839   1,374,319   (75,961,522)   (74,586,364)
Balance at the beginning (in shares) at Dec. 31, 2019   8,396,425            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss           (5,749,171)   (5,749,171)
Balance at the beginning at Dec. 31, 2019   $ 839   1,374,319   (75,961,522)   (74,586,364)
Balance at the beginning (in shares) at Dec. 31, 2019   8,396,425            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss               (19,349,948)
Balance at the end at Sep. 30, 2020 $ 216   24,784   (1,080)   23,920  
Balance at the end (in shares) at Sep. 30, 2020 2,156,250              
Balance at the beginning at Dec. 31, 2019   $ 839   1,374,319   (75,961,522)   (74,586,364)
Balance at the beginning (in shares) at Dec. 31, 2019   8,396,425            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss           (31,674,084)   (31,674,084)
Balance at the end at Dec. 31, 2020               (106,135,338)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss           (5,916,947)   (5,916,947)
Balance at the end at Jun. 30, 2020 $ 216 $ 856 24,784 1,611,049 (1,000) (106,135,338) 24,000 (106,135,338)
Balance at the end (in shares) at Jun. 30, 2020 2,156,250 2,765,097            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss         (80) (7,683,830) (80) (7,683,830)
Balance at the end at Sep. 30, 2020 $ 216   24,784   (1,080)   23,920  
Balance at the end (in shares) at Sep. 30, 2020 2,156,250              
Balance at the beginning at Jun. 30, 2020 $ 216 $ 856 24,784 1,611,049 (1,000) (106,135,338) 24,000 (106,135,338)
Balance at the beginning (in shares) at Jun. 30, 2020 2,156,250 2,765,097            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Sale of 3,146,454 Private Placement Warrants     2,831,809       2,831,809  
Net loss         (561,449)   (561,449)  
Balance at the end at Jun. 30, 2021 $ 201 $ 1,028 998,110 3,663,679 (562,449) (118,623,183) 435,862 (122,287,890)
Balance at the end (in shares) at Jun. 30, 2021 2,002,260 4,488,416            
Balance at the beginning at Dec. 31, 2020               (106,135,338)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss           (6,825,527)   (6,825,527)
Balance at the end at Mar. 31, 2021   $ 907   2,168,412   (112,403,451)   (114,572,770)
Balance at the end (in shares) at Mar. 31, 2021   3,271,804            
Balance at the beginning at Dec. 31, 2020               (106,135,338)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss               (29,232,518)
Balance at the end at Sep. 30, 2021 $ 201 $ 1,039 998,110 4,769,114 (1,392,079) (132,209,608) (393,768) (106,135,338)
Balance at the end (in shares) at Sep. 30, 2021 2,002,260 4,595,168            
Balance at the beginning at Mar. 31, 2021   $ 907   2,168,412   (112,403,451)   (114,572,770)
Balance at the beginning (in shares) at Mar. 31, 2021   3,271,804            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss           (7,715,120)   (7,715,120)
Balance at the end at Jun. 30, 2021 $ 201 $ 1,028 998,110 3,663,679 (562,449) (118,623,183) 435,862 (122,287,890)
Balance at the end (in shares) at Jun. 30, 2021 2,002,260 4,488,416            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss         (829,630) (14,691,871) (829,630) (14,691,871)
Balance at the end at Sep. 30, 2021 $ 201 $ 1,039 $ 998,110 $ 4,769,114 $ (1,392,079) $ (132,209,608) $ (393,768) $ (106,135,338)
Balance at the end (in shares) at Sep. 30, 2021 2,002,260 4,595,168